4 completed, 2 not yet recruiting, 2 terminated, 1 active not recruiting. 12 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 12 | Completed 4, Not yet recruiting 2, Terminated 2, Active not recruiting 1, Recruiting 1, Unknown 1, Withdrawn 1 |
Follow Ischemic Attack, Transient: new trials by email Literature Review of Ischemic Attack, Transient trials Research Report on Ischemic Attack, Transient
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Platelet Aggregation Function-Guided De-Escalation Antiplatelet Therapy in Patients With Acute Ischemic Stroke Clopidogrel, Aspirin - Ischemic Stroke, Transient Ischemic Attack | Phase 4 | Not yet recruiting | Sichuan Provincial People's Hospital | 3836 | 2026-06-01 | 2026-06-12 |
| StAtins in Frail OldEr Patients with Ischemic Stroke or Transient Ischemic Attack - the Randomized Controlled Trial Statin (atorvastatin, fluvastatin, pravastatin, rosuvastatin or simvastatin) - Ischemic Stroke, Transient Ischemic Attack | Phase 4 | Not yet recruiting | Prof. dr. Nathalie van der Velde | 612 | 2025-02-01 | 2025-01-21 |
| Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE Antiplatelet Drug, Warfarin - Antiphospholipid Syndrome, Ischemic Stroke | Phase 4 | Active not recruiting | Seoul National University Hospital | 200 | 2024-02-20 | 2026-09-11 |
| Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes Semaglutide Auto-Injector, Placebo - Diabetes Mellitus, Type 2, Stroke (CVA) or Transient Ischemic Attack | Phase 4 | Recruiting | University of Washington | 50 | 2024-01-11 | 2024-06-05 |
| The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack anti-thrombotic treatment using Aspirin (ASA 75-325mg) and Clopidogrel (75mg) - Transient Ischemic Attacks, Minor Stroke | Phase 4 | Withdrawn | University of Alberta | 2014-07-01 | 2022-05-27 | |
| Accelerated Atherosclerosis in High Risk Population Groups: An Assessment by Magnetic Resonance Imaging Statin therapy, Lifestyle modification - Atherosclerosis | Phase 4 | Terminated | Emory University | 9 | 2014-04-01 | 2018-09-11 |
| Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in Hypertensives all approved antihypertensive drugs; all approved statins - Stroke, Transient Ischemic Attack | Phase 4 | Completed | Istituto Auxologico Italiano | 200 | 2013-04-01 | 2024-02-20 |
| Rosuvastatin in African Americans With Cerebrovascular Disease Rosuvastatin - Stroke, Transient Ischemic Attack | Phase 4 | Terminated | Wayne State University | 20 | 2012-01-01 | 2013-11-05 |
| Efficacy and Cost-Effectiveness of Cost-free Pharmacotherapy for Smoking Cessation for High-risk Smokers With Cerebrovascular Disease Cost-Free Pharmacotherapy Group, Prescription Only Group - Cerebrovascular Disorders, Smoking Cessation | Phase 4 | Completed | Ottawa Heart Institute Research Corporation | 194 | 2009-12-01 | 2026-08-10 |
| Preventing Recurrent Vascular Events in Patients With Stroke or Transient Ischemic Attack Antihypertensive agents and lipid lowering therapy, Usual Care - Ischemic Stroke, Transient Ischemic Attacks | Phase 4 | Completed | University of Alberta | 279 | 2009-01-01 | 2018-10-15 |
| The Effectiveness and Safety of Butylphthalide Soft Capsules in Secondary Prevention of Ischemic Stroke Trial Butylphthalide Soft Capsules, Aspirin - Stroke, Transient Ischemic Attack | Phase 4 | Unknown | Peking Union Medical College Hospital | 1000 | 2008-08-01 | 2011-02-24 |
| ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial anticoagulation, aspirin and dipyridamole, aspirin alone - Brain Ischemia, Transient Ischemic Attack | Phase 4 | Completed | UMC Utrecht | 4500 | 1997-07-01 | 2007-03-22 |
Stroke (7) · Ischemic Stroke (4) · Cardiovascular Diseases (2) · Cerebrovascular Disorders (2) · Antiphospholipid Syndrome (1) · Arteriosclerosis (1) · Atherosclerosis (1) · Brain Ischemia (1) · Dementia (1) · Diabetes Mellitus, Type 2 (1) · Heart Failure (1) · Hypertension (1) · Myocardial Infarction (1) · Smoking Cessation (1)
Brain Diseases (12) · Central Nervous System Diseases (12) · Nervous System Diseases (12) · Vascular Diseases (12) · Brain Ischemia (11) · Cardiovascular Diseases (10) · Cerebrovascular Disorders (10) · Stroke (3) · Arterial Occlusive Diseases (2) · Arteriosclerosis (1) · Autoimmune Diseases (1) · Behavior (1) · Diabetes Mellitus (1) · Embolism and Thrombosis (1) · Endocrine System Diseases (1)
Rosuvastatin Calcium (4) · Aspirin (3) · Atorvastatin (2) · Clopidogrel (2) · Fluvastatin (2) · Pravastatin (2) · Simvastatin (2) · Adrenergic alpha-Antagonists (1) · Adrenergic beta-Antagonists (1) · Angiotensin Receptor Antagonists (1) · Angiotensin-Converting Enzyme Inhibitors (1) · Antihypertensive Agents (1) · Bupropion (1) · Calcium Channel Blockers (1) · Dipyridamole (1)
University of Alberta (2) · Emory University (1) · Istituto Auxologico Italiano (1) · Ottawa Heart Institute Research Corporation (1) · Peking Union Medical College Hospital (1) · Prof. dr. Nathalie van der Velde (1) · Seoul National University Hospital (1) · Sichuan Provincial People's Hospital (1) · UMC Utrecht (1) · University of Washington (1) · Wayne State University (1)
Canada (3) · United States (3) · China (2) · Netherlands (1) · Russia (1) · South Korea (1)
A. Algra, Professor (1) · Alberto Zanchetti (1) · Andrew Pipe, MD (1) · Ashfaq Shuaib, MD FRCPC (1) · Debbie Aitken, RN BScN (1) · Finlay A McAlister, MD, MSc (1) · Francis Kim, MD (1) · Grant Stotts, MD (1) · J. Gijn Van, Professor (1) · John Oshinski, PhD (1) · Kerri-Anne Mullen, MSc (1) · Lisheng Liu, MD (1) · Mary Ann Laplante, RN BScN (1) · Nathalie van der Velde, Prof. dr. (1) · Renske van den Berg, Prof. dr. (1)
PMID 16714187, PMID 17239798, PMID 21330625, PMID 24733770, PMID 24979303, PMID 25458657, PMID 32905623, PMID 36398903, PMID 41070271, PMID 41308951